165 related articles for article (PubMed ID: 6181257)
21. Macrophage activation: synergism between hybridoma MAF and poly(I). Poly(C) delivered by liposomes.
Pidgeon C; Schreiber RD; Schultz RM
J Immunol; 1983 Jul; 131(1):311-4. PubMed ID: 6408176
[TBL] [Abstract][Full Text] [Related]
22. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
[TBL] [Abstract][Full Text] [Related]
24. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
25. Partial purification of a macrophage-activating factor for glucose consumption (MAF-G) produced by a human T-cell hybridoma and its relation to a growth-promoting factor.
Osada H; Furukawa-Nakanishi K; Miyamoto D; Kobayashi Y; Osawa T
Lymphokine Res; 1989; 8(4):393-405. PubMed ID: 2509820
[TBL] [Abstract][Full Text] [Related]
26. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
Kelso A; Glasebrook AL
J Immunol; 1984 Jun; 132(6):2924-31. PubMed ID: 6202766
[TBL] [Abstract][Full Text] [Related]
27. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
28. Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes.
Prystowsky MB; Ely JM; Beller DI; Eisenberg L; Goldman J; Goldman M; Goldwasser E; Ihle J; Quintans J; Remold H; Vogel SN; Fitch FW
J Immunol; 1982 Dec; 129(6):2337-44. PubMed ID: 6216281
[TBL] [Abstract][Full Text] [Related]
29. Constitutive production of a non-interferon macrophage activating factor by HTLV-transformed T cells.
Lee JC
Lymphokine Res; 1986; 5 Suppl 1():S127-32. PubMed ID: 3023762
[TBL] [Abstract][Full Text] [Related]
30. Immunological functions of macrophages and their regulation by interferons.
Virelizier JL; Arenzana-Seisdedos F
Med Biol; 1985; 63(4):149-59. PubMed ID: 2419711
[TBL] [Abstract][Full Text] [Related]
31. Lymphokine production by human T cell hybridomas.
Le J; Vilcek J; Sadlik JR; Cheung MK; Balazs I; Sarngadharan MG; Prensky W
J Immunol; 1983 Mar; 130(3):1231-5. PubMed ID: 6401782
[TBL] [Abstract][Full Text] [Related]
32. Preparation and antitumor effect of macrophage activating factor (MAF) encapsulated in liposomes bearing a monoclonal anti-human melanoma (A375) antibody.
Watanabe Y; Uchida E; Higuchi M; Imai Y; Osawa T
J Biol Response Mod; 1987 Oct; 6(5):556-68. PubMed ID: 3316511
[TBL] [Abstract][Full Text] [Related]
33. The production of a macrophage-activating factor from rainbow trout Salmo gairdneri leucocytes.
Graham S; Secombes CJ
Immunology; 1988 Oct; 65(2):293-7. PubMed ID: 3056854
[TBL] [Abstract][Full Text] [Related]
34. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract][Full Text] [Related]
35. Interferon gamma: more than a MAF.
Peters PM; Svedersky LP; Shalaby MR; Palladino MA
Lymphokine Res; 1985; 4(3):265-73. PubMed ID: 3928982
[TBL] [Abstract][Full Text] [Related]
36. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
[TBL] [Abstract][Full Text] [Related]
37. T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants.
Raulet DH; Hünig T; Parker DC
J Immunol; 1982 Feb; 128(2):908-12. PubMed ID: 6798126
[TBL] [Abstract][Full Text] [Related]
38. Macrophage activating factor is not identical with immune interferon or a factor inducing differentiation of mouse myeloid leukemic cells.
Yamamoto Y; Tomida M; Hozumi M
Gan; 1982 Aug; 73(4):557-64. PubMed ID: 6818089
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells.
Zlotnik A; Shimonkevitz RP; Gefter ML; Kappler J; Marrack P
J Immunol; 1983 Dec; 131(6):2814-20. PubMed ID: 6196401
[TBL] [Abstract][Full Text] [Related]
40. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.
Schreiber RD; Altman A; Katz DH
J Exp Med; 1982 Sep; 156(3):677-89. PubMed ID: 7050288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
